SCOTTSDALE, Ariz., Dec. 2, 2019 /PRNewswire-PRWeb/ -- The NCPDP
Foundation Board of Trustees, who govern the 501(c)(3) nonprofit
charitable organization that is affiliated with NCPDP, has approved
$100,000 in funding to support two
research projects piloting the Beta version of NCPDP's Real-Time
Prescription Benefit (RTPB) Standard. The pilots can result in
identifying potential enhancements to the Standard, which is highly
anticipated by the healthcare industry and will be finalized by
August 2020.
A $50,000 grant is awarded to
DrFirst for a pilot in partnership with RxSense, and another
$50,000 grant is awarded to Johns
Hopkins Medicine for a study in partnership with Surescripts.
NCPDP's RTPB Standard provides a standardized format for the
prescriber, pharmacy and pharmacy claims processor to exchange
real-time information about a patient's drug benefit coverage and
out-of-pocket cost prior to prescribing and dispensing. The ability
to instantly access this data at the point of prescribing provides
unprecedented transparency which can increase speed to therapy and
can have a positive impact on medication adherence and health
outcomes.
The DrFirst project will evaluate the effectiveness of the NCPDP
RTPB Standard by testing and validating the accuracy and timeliness
of beneficiary information exchanged between the prescriber,
pharmacy, and pharmacy claims processor at the point of care.
Real-time information about an individual's prescription coverage
can help clinicians discuss options with patients while they are
together to improve medication adherence and reduce prescription
abandonment at the pharmacy.
The Johns Hopkins Medicine research team, led by Ashwini Davison MD, Jessica Merrey PharmD, and Danny Lee, MD will be characterizing the
real-world use of a RTPB tool and evaluating the impact of NCPDP's
RTPB Standard on key stakeholders. They hope to provide evidence
that RTPB tools have a positive effect on patients and reduce the
burden on prescribers, payers, and pharmacies when new medications
are prescribed.
The RTPB Standard was developed using NCPDP's multi-stakeholder,
consensus-building process and is designed to conform to providers'
workflows.
"We are committed to finalizing the Real-Time Prescription
Benefit Standard in preparation for industry adoption and
appreciate the support of the Foundation and the grantees whose
research can help fortify the standard," said Lee Ann Stember, President & CEO of
NCPDP.
NCPDP Foundation Chair, Mindy D.
Smith, BSPharm, R.Ph., MHA, explained, "The NCPDP
Foundation's funding of research that can identify potential
enhancements to the Real-Time Prescription Benefit Standard
contributes to making healthcare delivery better, safer and
cost-effective for the patient. The Standard also benefits
providers who can have better informed conversations with patients
to select the best medication based on the patient's individualized
needs."
About NCPDP Foundation
The NCPDP Foundation is a 501(c)(3) nonprofit charitable
organization headquartered in Scottsdale, Arizona and is affiliated
with the National Council for Prescription Drug Programs (NCPDP).
The NCPDP Foundation was established in December 2012 to support
research, education and charitable involvement within the
healthcare industry. For more information, visit
http://ncpdpfoundation.org.
SOURCE NCPDP Foundation